Dekho, asal mamla yeh hai ki Indrayani Biotech kaafi bade financial trouble mein chal rahi hai. Hinduja Leyland Finance ne 30 January 2026 ko unhe SARFAESI notice bheja hai. Yeh isliye hua kyuki company apne term loans ki EMI aur interest time pe bharne mein fail ho gayi, jiski wajah se unke loans ko NPA (Non-Performing Asset) declare kar diya gaya hai.
📉 Paisa Kitna Fasa Hai?
Hamare paas jo figures hain, unke hisaab se company ka Hinduja Leyland Finance ko direct outstanding amount ₹6,46,46,764.02 hai. Aur sirf itna hi nahi, saath dusri companies ke liye co-borrower hone ke naate Indrayani Biotech par ₹19,12,40,118.28 ka aur bhi paisa outstanding hai. Ye sab default 26 December 2025 ko record hua tha.
Aur jab sab loans ko mila dein, toh banks aur financial institutions se company ne kul ₹41,00,01,653/- ka loan liya hua hai. Short-term aur long-term debt ko mila kar dekha jaaye, toh company ka total financial indebtedness ₹54,48,47,022/- ho gaya hai.
🚩 Aage Kya Ho Sakta Hai?
Jab loan NPA declare ho jaata hai, toh iska matlab company apna loan ka bojh utha nahi pa rahi hai, jo ki financial health ke liye bilkul acchi baat nahi hai. SARFAESI Act lenders ko loan recover karne ke liye company ki assets pakadne ka haq deta hai. Toh sabse bada risk toh yahi hai ki Hinduja Leyland Finance company ki properties ko seize kar sakti hai.
Iske alawa, NPA hone se company ki credit rating ki toh band baj jayegi, jiski wajah se aage loan milna ya koi bhi financial transaction karna bahut mushkil ho jayega. Government aur regulators ki nazar bhi ab tej ho jayegi company par.
Investors ko ab yahi dekhna hoga ki company is notice par kya karti hai, koi solution nikaalti hai ya loan accounts ko theek karti hai, ya fir assets vapas karne padte hain. Company ke paas debt sambhalne ka koi solid plan hai ya nahi, ye dekhna sabse important hoga.